Clinical trial
Endothelin-1 Receptor Blockade in Resistant Hypertension
NCT04388124
Study timeline
Study start (actual)2021-10-20Date precision: day
Registry last updated2026-02-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Resistant Hypertensionunresolved
Interventions
BosentanDRUG · verified · RxNorm: bosentan
PlaceboDRUG
Sponsors & collaborators
University Hospital, Rouenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04388124 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.